Summary#
This bill would phase out nonessential uses of perfluoroalkyl or polyfluoroalkyl substances (PFAS) and stop releases of PFAS into the environment. It directs the EPA Administrator to seek a 10-year agreement with the National Academies to review and recommend which uses are "essential." Manufacturers and users must report annually on PFAS uses, releases, alternatives, and exposure. The bill sets deadlines to stop selling many PFAS-containing consumer products in 1 to 5 years, and requires a full phaseout of nonessential uses within 10 years. It makes it unlawful, after 10 years, to release PFAS above validated detection thresholds and requires EPA rulemaking to set schedules and methods. The bill allows limited research exceptions and authorizes inspections, monitoring, civil and criminal enforcement, and citizen suits with specified notice periods. It creates two Centers of Excellence for PFAS detection and remediation, authorizes funds for EPA activities, sets up fee-based funds for reports and petitions, and includes provisions affecting Federal agency procurement, State authority, CERCLA timing rules, and bankruptcy stay exceptions for persistent, bioaccumulative, and toxic (PBT) chemical claims.
What it means for you#
- Manufacturers and users: You must submit a plan within 3 years to phase out nonessential PFAS uses and begin annual reporting once EPA issues rules. You may be barred from selling many PFAS-containing products on the schedules in the bill. You can apply to transfer existing stocks to approved research consortia. You may face inspections, orders, civil penalties, and criminal penalties for reckless violations.
- Consumers and communities: Certain consumer products that contain PFAS would be phased out on set timelines, and new testing and remediation centers would be created to support local water and remediation work.
- Researchers and public agencies: The bill funds and directs creation of Centers of Excellence to develop and share PFAS detection and remediation methods and makes some PFAS use allowable for research if EPA approves.
- Citizens and states: The bill preserves State authority to impose more stringent rules. Any person may bring certain citizen suits after giving notice to EPA, the State, and alleged violators according to the bill’s timelines.
Expenses#
- The bill authorizes the Administrator to receive "such sums as may be necessary" to carry out Title I for fiscal years 2027 through 2036.
- It directs $25,000,000 from Department of Defense amounts for fiscal year 2027 to be made available to EPA to establish the Centers of Excellence, available until September 30, 2036.
- The EPA must complete a workload analysis and set fees for annual reports and petitions by rulemaking within a year of that analysis. If EPA does not finalize these fees within 2 years, the bill sets default minimum fees of $100,000 per annual report and $100,000 per petition (with possible lower amounts for small manufacturers).
- The bill establishes two Treasury funds (PFAS Report Assessment Fund and PFAS Petition Assessment Fund) to hold collected fees and any appropriations to be used for administration of reporting and petition processes.
- No publicly available information on total program costs or net economic impacts is provided in the bill text.
Proponents' View#
The bill states policy goals that frame proponents' reasons: contamination should be remediated to levels that do not present unreasonable risk; destruction and safe disposal of PFAS should be prioritized; use of PFAS in consumer products should be eliminated; and when PFAS use is essential and no safer alternative exists, the chemicals should be replaced by safer substitutes. The bill emphasizes improving transparency, supporting research and development of safer alternatives, and protecting human health and the environment.
Opponents' View#
No publicly available information.